Anpac Bio-Medical Science ADR (ANPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANPC | AMGN | VRTX | BMY | GILD |
| Company | Anpac Bio-Medical Science ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 4.57 | 275.01 | 458.06 | 58.84 | 93.50 |
| High | 4.65 | 275.36 | 465.90 | 59.53 | 94.22 |
| Low | 4.25 | 271.48 | 456.86 | 58.69 | 92.03 |
| Last | 4.37 | 272.58 | 462.10 | 59.38 | 92.13 |
| Change | -0.25 | -1.75 | +2.18 | +0.54 | -1.26 |
| % Change | -5.41% | -0.64% | +0.47% | +0.92% | -1.35% |
| Volume | 35,700 | 3,970,300 | 1,115,300 | 7,277,000 | 4,470,700 |
| 20-Day Average Volume | 29,135 | 4,673,665 | 1,376,875 | 11,103,835 | 7,318,660 |
| Previous Close | 4.62 | 274.33 | 459.92 | 58.84 | 93.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.67 | 288.82 | 469.52 | 58.37 | 91.82 |
| 20-Day Raw Stochastic | 3.61% | 20.98% | 22.84% | 76.09% | 47.19% |
| 20-Day Relative Strength | 40.18% | 31.35% | 46.49% | 60.90% | 55.67% |
| Weighted Alpha | -31.90 | -7.29 | +22.48 | +27.82 | +25.80 |
| Today's Opinion | 40% Sell | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 40% Sell | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Sell | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.16% since 05/12/23 | -3.64% since 11/29/24 | -1.29% since 11/29/24 | +0.27% since 11/29/24 | -0.49% since 11/29/24 |
| Low | 4.19 on 05/16/23 | 271.48 on 12/06/24 | 450.00 on 12/04/24 | 57.59 on 12/04/24 | 89.86 on 12/04/24 |
| High | 5.75 on 05/15/23 | 282.39 on 12/02/24 | 468.51 on 12/03/24 | 60.09 on 12/03/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | -4.17% since 04/19/23 | -15.29% since 11/06/24 | -6.39% since 11/06/24 | +7.42% since 11/06/24 | +0.48% since 11/06/24 |
| Low | 4.19 on 05/16/23 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 53.97 on 11/08/24 | 86.08 on 11/19/24 |
| High | 9.17 on 05/02/23 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -52.86% since 02/17/23 | -14.97% since 09/06/24 | -1.26% since 09/06/24 | +21.93% since 09/06/24 | +17.04% since 09/06/24 |
| Low | 3.49 on 04/13/23 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.55 on 09/09/24 | 78.36 on 09/09/24 |
| High | 9.19 on 02/21/23 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +12.92% since 11/18/22 | -10.83% since 06/06/24 | -4.83% since 06/06/24 | +45.25% since 06/06/24 | +44.29% since 06/06/24 |
| Low | 3.02 on 11/22/22 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 |
| High | 11.99 on 01/19/23 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,234 | 147,461,424 | 118,442,736 | 119,337,936 | 116,388,784 |
| Shares Outstanding, K | 969 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 1,750,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -14,770,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 437,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -31,904,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.56 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 12/19/22 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/30/23 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 0.00 | 49.89 | 20.67 |